SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-305948
Filing Date
2023-12-29
Accepted
2023-12-29 16:02:00
Documents
13
Period of Report
2023-12-22
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d736040d8k.htm   iXBRL 8-K 29680
  Complete submission text file 0001193125-23-305948.txt   200759

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rnlx-20231222.xsd EX-101.SCH 3363
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rnlx-20231222_def.xml EX-101.DEF 14731
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rnlx-20231222_lab.xml EX-101.LAB 24823
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rnlx-20231222_pre.xml EX-101.PRE 15689
7 EXTRACTED XBRL INSTANCE DOCUMENT d736040d8k_htm.xml XML 6209
Mailing Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE
Business Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE 44 29 2071 0570
Renalytix plc (Filer) CIK: 0001811115 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39387 | Film No.: 231527615
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)